Optimizing In Vitro Candidates for Radiopharmaceutical Development

Circle Oncodesign Services

Overcoming preclinical challenges around radionuclide selection, biodistribution, circulation, and clearance.

The rapid growth of radiopharmaceuticals is creating new opportunities for oncology drug developers, but success requires more than attaching a radionuclide to a promising in vitro compound.

View this webinar and learn how to:

  • Understand the challenges of translating promising in vitro candidates into radiopharmaceuticals.
  • Identify how pre-targeting and other optimization strategies can support successful radiopharmaceutical development.
  • Assess the impact of radionuclide and chelator selection on candidate design.
  • Explain how biodistribution, circulation time, and clearance influence therapeutic and diagnostic performance.